Correspondence 0001193125-24-024042 from Metagenomi Therapeutics, Inc. (MGX)
Metagenomi Therapeutics, Inc.
Date: Feb. 5, 2024 · CIK: 0001785279 · Accession: 0001193125-24-024042
AI Filing Summary & Sentiment
File numbers found in text: 333-276413
Letter
VIA EDGAR AND FEDERAL EXPRESS United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attention: Jenn Do, Angela Connell, Tyler Howes and Suzanne Hayes Re: Metagenomi, Inc. Risa Stack Resignation Letter
Dear Ladies and Gentlemen:
On behalf of Metagenomi, Inc. (the “Company”), we submit the enclosed resignation letter (the “Resignation Letter”) of Risa Stack, a member of the board of directors (the “Board”) of the Company. The Resignation Letter was delivered to the Company to inform it that Ms. Stack will automatically resign as a member of the Board, effective as of immediately prior to, and contingent upon, the effectiveness of the Company’s registration statement on Form S-1.
This letter is being furnished to the staff of the Division of Corporation Finance (the “Staff”) of the U.S. Securities and Exchange Commission in accordance with Section 11(b)(1) of the Securities Act of 1933, as amended, to notify the Staff that Ms. Stack will not be responsible for the contents of the Company’s registration statement on Form S-1 (File No. 333-276413), including any amendments thereto.
If you should have any questions regarding these matters, please contact the undersigned at (212) 813–8853.
Sincerely,
/s/ Edwin M. O’Connor
Edwin M. O’Connor, Esq.
cc:
Brian C. Thomas, Ph.D., Metagenomi, Inc.
Mitchell S. Bloom, Goodwin Procter LLP
Justin S. Platt, Goodwin Procter LLP
January 19, 2024
Board of Directors
Metagenomi, Inc.
1545 Park Avenue
Emeryville, CA 94608
Re: Director Resignation
Ladies and Gentlemen:
I, Risa Stack, write to inform you that I hereby automatically resign from the board of directors (the “Board”) of Metagenomi, Inc., a Delaware corporation (the “Company”), and all committees of the Board, effective as of immediately prior to, and contingent upon, the effectiveness of the Company’s registration statement on Form S-1 in connection with the Company’s initial public offering, and that I will not be responsible for any part of such registration statement.
Very truly yours,
/s/ Risa Stack
Show Raw Text
CORRESP 1 filename1.htm CORRESP Goodwin Procter LLP 620 8th Avenue New York, NY 10018 goodwinlaw.com +1 212 813 8800 February 5, 2024 VIA EDGAR AND FEDERAL EXPRESS United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Attention: Jenn Do, Angela Connell, Tyler Howes and Suzanne Hayes Re: Metagenomi, Inc. Risa Stack Resignation Letter Dear Ladies and Gentlemen: On behalf of Metagenomi, Inc. (the “Company”), we submit the enclosed resignation letter (the “Resignation Letter”) of Risa Stack, a member of the board of directors (the “Board”) of the Company. The Resignation Letter was delivered to the Company to inform it that Ms. Stack will automatically resign as a member of the Board, effective as of immediately prior to, and contingent upon, the effectiveness of the Company’s registration statement on Form S-1. This letter is being furnished to the staff of the Division of Corporation Finance (the “Staff”) of the U.S. Securities and Exchange Commission in accordance with Section 11(b)(1) of the Securities Act of 1933, as amended, to notify the Staff that Ms. Stack will not be responsible for the contents of the Company’s registration statement on Form S-1 (File No. 333-276413), including any amendments thereto. If you should have any questions regarding these matters, please contact the undersigned at (212) 813–8853. Sincerely, /s/ Edwin M. O’Connor Edwin M. O’Connor, Esq. cc: Brian C. Thomas, Ph.D., Metagenomi, Inc. Mitchell S. Bloom, Goodwin Procter LLP Justin S. Platt, Goodwin Procter LLP January 19, 2024 Board of Directors Metagenomi, Inc. 1545 Park Avenue Emeryville, CA 94608 Re: Director Resignation Ladies and Gentlemen: I, Risa Stack, write to inform you that I hereby automatically resign from the board of directors (the “Board”) of Metagenomi, Inc., a Delaware corporation (the “Company”), and all committees of the Board, effective as of immediately prior to, and contingent upon, the effectiveness of the Company’s registration statement on Form S-1 in connection with the Company’s initial public offering, and that I will not be responsible for any part of such registration statement. Very truly yours, /s/ Risa Stack Risa Stack